REGULATED PRESS RELEASE published on 01/16/2024 at 07:01, 2 years 8 months ago bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D bioMérieux, a world leader in in vitro diagnostics, announces the appointment of two new Executive Committee members, Dr. Charles K. Cooper and Céline Roger-Dalbert, to lead Medical Affairs and Research & Development, respectively. Dr. Cooper brings extensive medical and leadership background from Siemens Healthcare Diagnostics and U.S. Food & Drug Administration, while Céline Roger-Dalbert boasts over 25 years of in vitro diagnostic experience, with significant contributions to new product launches and over 20 patent applications. Their nominations signify bioMérieux's commitment to addressing global patients' needs and driving innovation, aligning with the company's strategy. For more information, visit www.biomerieux.com. BioMérieux Medical Affairs Research And Development In Vitro Diagnostics Executive Committee Members
REGULATED PRESS RELEASE published on 01/08/2024 at 08:22, 2 years 9 months ago bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance bioMérieux has acquired LUMED, a software company specializing in clinical decision support systems to optimize antimicrobial prescriptions and monitor healthcare-associated infections. This acquisition reinforces bioMérieux's commitment to combat antimicrobial resistance and improve infection prevention and control through advanced software solutions. BioMérieux LUMED Antimicrobial Resistance Clinical Decision Support System Infection Prevention And Control
REGULATED PRESS RELEASE published on 10/26/2023 at 07:01, 2 years 11 months ago bioMérieux – Third-Quarter 2023 Business Review
REGULATED PRESS RELEASE published on 10/19/2023 at 08:00, 2 years 11 months ago bioMérieux makes strategic investment in Oxford Nanopore
REGULATED PRESS RELEASE published on 10/13/2023 at 07:02, 2 years 11 months ago bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic brain injury, including concussion
Published on 10/09/2026 at 08:00, 35 minutes ago Caledonia Mining Corporation Blanket Mine Q3 Production Update and Revised Guidance for 2026
Published on 10/08/2026 at 22:05, 10 hours 30 minutes ago Rochon Family Executes Additional Strategic Purchase of $26.8 Million of AIAI Holdings Shares
Published on 10/08/2026 at 20:30, 12 hours 5 minutes ago Guanajuato Silver Completes San Ignacio to Bolanitos Connection Tunnel
Published on 10/08/2026 at 14:31, 18 hours 4 minutes ago First Breach Expands Hiring Initiative to Support Ammunition Production Growth and Planned Drone Manufacturing Operations
Published on 10/08/2026 at 14:30, 18 hours 5 minutes ago Predictiv AI's Shift AI Completes AWS Foundational Technical Review and Expands Aviation Visibility Through AWS Solutions Library
Published on 10/09/2026 at 08:14, 21 minutes ago Cantourage and Green Karat deepen strategic partnership following EU-GMP certification
Published on 10/09/2026 at 07:45, 50 minutes ago Chelsea FC announces new global partnership with GAC
Published on 10/09/2026 at 07:45, 50 minutes ago New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
Published on 10/08/2026 at 18:30, 14 hours 5 minutes ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 14 hours 35 minutes ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 14 hours 50 minutes ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
Published on 10/07/2026 at 18:19, 1 day 14 hours ago Outstanding shares and voting rights statement at 30 September 2026